Project MB201 selected as National New Drug Development Project (2022.05.10) Date2022-05-11 View604 http://www.biospectator.com/view/news_view.php?varAtcId=16426 Prev Patent registered at Korea Intellectual Property Office regarding bispecific antibody platform technology Next IR presentation at Korea Bio Investment Conference (2022.07.11) back to list
